RPGR

RPGR
National Center for Biotechnology Information, U.S. National Library of Medicine · Public domain · source
Name	RPGR
Organism	Human

RPGR Retinitis pigmentosa GTPase regulator (RPGR) is a ciliary and photoreceptor-associated protein implicated in inherited retinal degeneration. Discovered through genetic mapping of X-linked retinal disease, RPGR has been studied alongside other vision genes and ciliopathy factors across clinical, molecular, and model-organism research. Its dysfunction links to photoreceptor structure, intraflagellar transport, and human genetic variation characterized by ophthalmology and molecular genetics consortia.

Structure and Isoforms

The protein exhibits an N-terminal RCC1-like domain shared with RCC1, and multiple alternatively spliced C-terminal isoforms described in studies from Genentech, NIH, and academic groups at University of California, San Francisco and University College London. Isoforms include a constitutive isoform enriched in testes and a retina-specific exon (ORF15) characterized by a glycine- and glutamate-rich region referenced by sequencing centers such as Sanger Institute and laboratories at Harvard Medical School. Structural analyses reference comparisons to RCC1 family members and motifs conserved across species including Mus musculus, Drosophila melanogaster, and Danio rerio. Post-translational modifications reported by proteomics groups at Max Planck Institute include phosphorylation sites identified using mass spectrometry platforms developed at Broad Institute.

Function and Cellular Localization

RPGR localizes to photoreceptor connecting cilia and the transition zone, as shown by immunolabeling studies from Cold Spring Harbor Laboratory and imaging cores at Johns Hopkins University. It interacts with ciliary trafficking machinery and is implicated in the regulation of microtubule-based transport studied in labs at MIT and Stanford University. Functional roles were elucidated in collaborations between clinical centers such as Moorfields Eye Hospital and research institutes including Institut Pasteur, demonstrating roles in outer segment disc morphogenesis, protein sorting, and maintenance of rod and cone structure. Cell biology studies often reference proximity to markers like CEP290 and components studied by groups at University of Oxford.

Genetics and Disease Associations

Mutations clustered in the ORF15 exon and other coding regions were cataloged by genetic consortia including ClinVar, HGMD, and collaborative networks at Bascom Palmer Eye Institute. RPGR-linked alleles produce X-linked retinitis pigmentosa and variable cone-rod dystrophy phenotypes reported in cohorts from St. Thomas' Hospital, Wills Eye Hospital, and multicenter trials coordinated by NEI. Population genetics analyses referenced data from 1000 Genomes Project and gnomAD highlight recurrent indels and frameshifts. Genotype–phenotype correlations were explored in studies at King's College London and University of Miami, with modifier loci proposed from genome-wide association studies led by teams at Broad Institute.

Molecular Pathways and Interactions

Biochemical and interactome mapping identified partners including RPGRIP1, PDE6D, CEP290, and members of the BBSome characterized by groups at Howard Hughes Medical Institute, University of Pennsylvania, and University of California, Berkeley. Studies integrating proteomics at EMBL and interactome databases curated by STRING indicate RPGR participates in intraflagellar transport, small GTPase regulation, and ubiquitin-mediated processes studied by labs at University of Cambridge and Yale University. Pathway analyses reference ciliopathy networks overlapping with genes implicated in Bardet–Biedl syndrome and Leber congenital amaurosis described in clinical genetics centers like Mayo Clinic.

Animal Models and Experimental Studies

Murine models with targeted alleles were developed by research groups at The Jackson Laboratory and used to assess photoreceptor degeneration, electrophysiology, and gene-replacement approaches evaluated at University of Florida and Columbia University. Canine models maintained by veterinary ophthalmology programs at University of Pennsylvania School of Veterinary Medicine recapitulate human phenotypes and were instrumental for preclinical studies by teams at University of Pennsylvania and industry partners including Spark Therapeutics. Zebrafish and Drosophila models used by University of Sheffield and University of Zurich contributed to understanding ciliary assembly and developmental roles. Functional rescue experiments used viral vectors characterized by translational groups at Genethon and Oxford BioMedica.

Clinical Presentation and Diagnosis

Affected individuals present with nyctalopia, peripheral visual field constriction, and progression to central vision loss documented in clinical series from Johns Hopkins Hospital and Wills Eye Hospital. Fundus imaging, optical coherence tomography protocols from Heidelberg Engineering, and electroretinography standards by the International Society for Clinical Electrophysiology of Vision are used for diagnosis and monitoring. Genetic testing and counseling are provided through diagnostic laboratories affiliated with Mayo Clinic Laboratories, Invitae, and academic genetics services at University College London Hospitals.

Therapeutic Approaches and Management

Therapeutic development includes gene augmentation strategies tested by Spark Therapeutics, antisense oligonucleotide approaches investigated at Salk Institute, and genome-editing preclinical work by teams at Broad Institute and CRISPR Therapeutics. Clinical trials coordinated by NIH and industry consortia assess safety and efficacy of AAV-mediated RPGR delivery, with patient cohorts enrolled through centers such as Moorfields Eye Hospital and Bascom Palmer Eye Institute. Supportive management follows standards from American Academy of Ophthalmology and low-vision rehabilitation services provided at Johns Hopkins Wilmer Eye Institute.

Category:Proteins Category:Retinal diseases